Home › Companies › ORTHOPEDIATRICS CORP. › 2023-2024

ORTHOPEDIATRICS CORP. 2023-2024 Proxy Voting Records

Compiled from SEC Form N-PX filings and ORTHOPEDIATRICS CORP.’s Form 8-K, filed May 28, 2024 (Item 5.07 on EDGAR). Page generated October 14, 2026.

  • 6Ballot items
  • 177Asset managers
  • 1,142Fund votes
  • May 24, 2024Meeting date

Results at a glance

Meeting of May 24, 2024: 6 items on ORTHOPEDIATRICS CORP.’s Form 8-K, filed May 28, 2024: 3 elected · 3 approved.

Material dissent

Material dissent: a director nominee under 80% of the votes cast, say-on-pay under 70%, any other item the board put forward under 80%, or a shareholder proposal with more than 50%, on the company’s own Form 8-K tally. How this is decided

Proxy season: 2023-2024 2024-2025 2025-2026

Explore ORTHOPEDIATRICS CORP. in the interactive database Compare manager voting policies

Official 2023-2024 meeting results reported by ORTHOPEDIATRICS CORP.

These tallies are ORTHOPEDIATRICS CORP.’s own, as disclosed to the U.S. Securities and Exchange Commission on Form 8-K, filed May 28, 2024 (Item 5.07, “Submission of Matters to a Vote of Security Holders”). They cover every share voted at the meeting, not just the funds that file Form N-PX.

ORTHOPEDIATRICS CORP. — official shareholder meeting results, meeting held May 24, 2024
Ballot itemForAgainst AbstainWithheldBroker non-votesSupport (of votes cast)Reported outcomeVoting standard
Elect Director: David R. Bailey 18,199,037---- 1,790,600727,703 91%Elected—
Elect Director: Marie C. Infante 12,686,531---- 7,186,996843,813 64%Elected—
Elect Director: Jimmy D. McDonald 14,265,857---- 5,721,728729,755 71%Elected—
Approval, on an advisory basis, of the compensation of the Company's named executive officers The Company's stockholders approved the compensation of the Company's named executive officers by voting as follows: 19,430,742258,906304,480 --723,212 99%Approved—
Approval of the OrthoPediatrics Corp. 2024 Incentive Award Plan The Company's stockholders approved the OrthoPediatrics Corp. 18,409,9071,279,054305,167 --723,212 94%Approved—
Approval, on an advisory basis, of the appointment of Deloitte & Touche LLP as the Company's Independent Registered Public Accounting Firm for our Fiscal Year Ending December 31, 2024 The Company's stockholders approved the appointment by the Audit Committee o 20,565,406150,3661,568 ---- 99.2%Approved—

Source: ORTHOPEDIATRICS CORP., Form 8-K, filed with the SEC on May 28, 2024 — read the filing on EDGAR.

How asset managers voted at the ORTHOPEDIATRICS CORP. 2023-2024 meeting

Each item below shows how the 177 asset managers that disclosed a ORTHOPEDIATRICS CORP. vote in their SEC Form N-PX filings actually voted. Share totals are the shares those managers' funds voted, summed across every fund they report.

1. Elect Director: David R. Bailey

Official resultDIRECTOR ELECTIONSReported outcome: Elected

Combines 4 wordings of this item as funds reported it.

91% Majority: yes · of votes cast

FOR 91%
FOR: 18,199,037WITHHELD: 1,790,600
Details: description as filed, official tally, votes by 59 asset managers

Description as filed by funds: To elect three (3) directors, each to serve until the 2027 annual meeting of our stockholders: David R. Bailey

ORTHOPEDIATRICS CORP.’s own tally for this item (“Elect Director: David R. Bailey”): 18,199,037 for, 1,790,600 withheld, per its Form 8-K filed May 28, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “(the "Company") held its 2024 Annual Meeting of Stockholders and the Company's stockholders voted on the following matters: Election of Directors The nominees below were elected to serve as directors for a term that will last until the Company's 2027 Annual Meeting of Stockholders or until his or h…”
Support: 91% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.

The 59 asset managers below reported 5,049,623 for, 345,635 withheld.

FOR
FOR: 5,049,623WITHHOLD: 345,635
Largest asset managers voting on “To elect three (3) directors, each to serve until the 2027 annual meeting of our stockholders: David R. Bailey” at ORTHOPEDIATRICS CORP., 2023-2024
Asset managerForAgainst AbstainWithheldVote
Brown Capital Management Mutual Funds1,220,1410 00For
Vanguard846,2120 00For
Brown Advisory Funds508,7290 00For
Fidelity354,9890 00For
WASATCH FUNDS TRUST351,2260 00For
Dimensional00 0331,306Withhold
BlackRock298,2750 00For
Jackson National195,2250 06,509For
Principal188,8260 00For
Charles Schwab124,4280 00For
PARADIGM FUNDS119,4000 00For
Goldman Sachs102,7720 00For
State Street92,6000 0563For
Victory Capital76,6770 00For
Nationwide64,9520 00For
Royce55,6230 00For
New York Life52,4930 00For
Equitable41,1650 00For
MoA Funds Corp38,0390 00For
TIAA37,0460 00For
QUANTITATIVE MASTER SERIES LLC29,6090 00For
BUFFALO FUNDS28,4900 00For
CLEARWATER INVESTMENT TRUST28,0870 00For
PACE SELECT ADVISORS TRUST22,4780 00For
Harbor Funds II18,7750 00For

Showing the 25 largest of 59 asset managers. See all 59 in the interactive database.

2. Elect Director: Jimmy D. McDonald

Official resultDIRECTOR ELECTIONSReported outcome: Elected

Combines 5 wordings of this item as funds reported it.

71% Majority: yes · of votes cast

FOR 71%WITHHELD
FOR: 14,265,857WITHHELD: 5,721,728
Details: description as filed, official tally, votes by 59 asset managers

Description as filed by funds: To elect three (3) directors, each to serve until the 2027 annual meeting of our stockholders: Jimmy D. McDonald

ORTHOPEDIATRICS CORP.’s own tally for this item (“Elect Director: Jimmy D. McDonald”): 14,265,857 for, 5,721,728 withheld, per its Form 8-K filed May 28, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “(the "Company") held its 2024 Annual Meeting of Stockholders and the Company's stockholders voted on the following matters: Election of Directors The nominees below were elected to serve as directors for a term that will last until the Company's 2027 Annual Meeting of Stockholders or until his or h…”
Support: 71% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.

The 59 asset managers below reported 3,758,529 for, 1,636,729 withheld.

FORWITHHOLD
FOR: 3,758,529WITHHOLD: 1,636,729
Largest asset managers voting on “To elect three (3) directors, each to serve until the 2027 annual meeting of our stockholders: Jimmy D. McDona” at ORTHOPEDIATRICS CORP., 2023-2024
Asset managerForAgainst AbstainWithheldVote
Brown Capital Management Mutual Funds1,220,1410 00For
Vanguard846,2120 00For
Brown Advisory Funds00 0508,729Withhold
Fidelity354,9890 00For
WASATCH FUNDS TRUST351,2260 00For
Dimensional00 0331,306Withhold
BlackRock298,2750 00For
Jackson National00 0201,734Withhold
Principal00 0188,826Withhold
Charles Schwab124,4280 00For
PARADIGM FUNDS119,4000 00For
Goldman Sachs00 0102,772Withhold
State Street91,5890 01,574For
Victory Capital00 076,677Withhold
Nationwide60,8550 04,097Mixed
Royce55,6230 00For
New York Life00 052,493Withhold
Equitable41,1650 00For
MoA Funds Corp00 038,039Withhold
TIAA00 037,046Withhold
QUANTITATIVE MASTER SERIES LLC29,6090 00For
BUFFALO FUNDS28,4900 00For
CLEARWATER INVESTMENT TRUST28,0870 00For
PACE SELECT ADVISORS TRUST22,4780 00For
Harbor Funds II18,7750 00For

Showing the 25 largest of 59 asset managers. See all 59 in the interactive database.

3. Elect Director: Marie C. Infante

Official resultDIRECTOR ELECTIONSReported outcome: Elected

Combines 4 wordings of this item as funds reported it.

64% Majority: yes · of votes cast

FOR 64%WITHHELD
FOR: 12,686,531WITHHELD: 7,186,996
Details: description as filed, official tally, votes by 59 asset managers

Description as filed by funds: To elect three (3) directors, each to serve until the 2027 annual meeting of our stockholders: Marie C. Infante

ORTHOPEDIATRICS CORP.’s own tally for this item (“Elect Director: Marie C. Infante”): 12,686,531 for, 7,186,996 withheld, per its Form 8-K filed May 28, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “(the "Company") held its 2024 Annual Meeting of Stockholders and the Company's stockholders voted on the following matters: Election of Directors The nominees below were elected to serve as directors for a term that will last until the Company's 2027 Annual Meeting of Stockholders or until his or h…”
Support: 64% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.

The 59 asset managers below reported 3,116,656 for, 2,278,602 withheld.

FORWITHHOLD
FOR: 3,116,656WITHHOLD: 2,278,602
Largest asset managers voting on “To elect three (3) directors, each to serve until the 2027 annual meeting of our stockholders: Marie C. Infant” at ORTHOPEDIATRICS CORP., 2023-2024
Asset managerForAgainst AbstainWithheldVote
Brown Capital Management Mutual Funds1,220,1410 00For
Vanguard846,2120 00For
Brown Advisory Funds00 0508,729Withhold
Fidelity346,4160 08,573For
WASATCH FUNDS TRUST351,2260 00For
Dimensional00 0331,306Withhold
BlackRock00 0298,275Withhold
Jackson National00 0201,734Withhold
Principal00 0188,826Withhold
Charles Schwab00 0124,428Withhold
PARADIGM FUNDS119,4000 00For
Goldman Sachs00 0102,772Withhold
State Street5150 092,648Withhold
Victory Capital00 076,677Withhold
Nationwide60,8550 04,097Mixed
Royce55,6230 00For
New York Life00 052,493Withhold
Equitable00 041,165Withhold
MoA Funds Corp00 038,039Withhold
TIAA00 037,046Withhold
QUANTITATIVE MASTER SERIES LLC00 029,609Withhold
BUFFALO FUNDS28,4900 00For
CLEARWATER INVESTMENT TRUST28,0870 00For
PACE SELECT ADVISORS TRUST22,4780 00For
Harbor Funds II18,7750 00For

Showing the 25 largest of 59 asset managers. See all 59 in the interactive database.

4. Approval of the OrthoPediatrics Corp. 2024 Incentive Award Plan The Company's stockholders approved the OrthoPediatrics…

Official resultCOMPENSATIONReported outcome: Approved

Combines 3 wordings of this item as funds reported it.

94% Approved · of votes cast

FOR 94%
FOR: 18,409,907AGAINST: 1,279,054
Details: description as filed, official tally, votes by 58 asset managers

Description as filed by funds: To approve the Company's 2024 Incentive Award Plan.

ORTHOPEDIATRICS CORP.’s own tally for this item (“Approval of the OrthoPediatrics Corp. 2024 Incentive Award Plan The Company's stockholders approved the OrthoPediatrics Corp.”): 18,409,907 for, 1,279,054 against — passed, per its Form 8-K filed May 28, 2024 (Item 5.07).

Reported outcome: Approved, in the filing’s own words: “2024 Incentive Award Plan The Company's stockholders approved the OrthoPediatrics Corp.”
Support: 94% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 58 asset managers below reported 5,135,377 for, 140,481 against.

FOR
FOR: 5,135,377AGAINST: 140,481
Largest asset managers voting on “To approve the Company's 2024 Incentive Award Plan.” at ORTHOPEDIATRICS CORP., 2023-2024
Asset managerForAgainst AbstainWithheldVote
Brown Capital Management Mutual Funds1,220,1410 00For
Vanguard846,2120 00For
Brown Advisory Funds508,7290 00For
Fidelity354,9890 00For
WASATCH FUNDS TRUST351,2260 00For
Dimensional331,3060 00For
BlackRock298,2750 00For
Jackson National201,7340 00For
Principal188,8260 00For
Charles Schwab0124,428 00Against
Goldman Sachs102,7720 00For
State Street92,672491 00For
Victory Capital76,6770 00For
Nationwide64,9520 00For
Royce55,6230 00For
New York Life52,4930 00For
Equitable41,1650 00For
MoA Funds Corp38,0390 00For
TIAA37,0460 00For
QUANTITATIVE MASTER SERIES LLC29,6090 00For
BUFFALO FUNDS28,4900 00For
CLEARWATER INVESTMENT TRUST28,0870 00For
PACE SELECT ADVISORS TRUST22,4780 00For
Harbor Funds II18,7750 00For
Lincoln Financial14,8890 00For

Showing the 25 largest of 58 asset managers. See all 58 in the interactive database.

5. Approval, on an advisory basis, of the compensation of the Company's named executive officers The Company's…

Official resultFund totals may overlapSECTION 14A SAY-ON-PAY VOTESCOMPENSATIONReported outcome: Approved

Combines 8 wordings of this item as funds reported it.

99% Approved · of votes cast

FOR 99%
FOR: 19,430,742AGAINST: 258,906
Details: description as filed, official tally, votes by 176 asset managers

Description as filed by funds: To approve, on an advisory basis, the compensation of our named executive officers.

ORTHOPEDIATRICS CORP.’s own tally for this item (“Approval, on an advisory basis, of the compensation of the Company's named executive officers The Company's stockholders approved the compensation of the Company's named executive officers by voting as follows:”): 19,430,742 for, 258,906 against — passed, per its Form 8-K filed May 28, 2024 (Item 5.07).

Reported outcome: Approved, in the filing’s own words: “Approval, on an advisory basis, of the compensation of the Company's named executive officers The Company's stockholders approved the compensation of the Company's named executive officers by voting as follows:”
Support: 99% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice).

Fund voting reports: 59 asset managers voting on “To approve, on an advisory basis, the compensation of our named executive officers.” at ORTHOPEDIATRICS CORP., 2023-2024
Asset managerForAgainst AbstainWithheldVote
Brown Capital Management Mutual Funds1,220,1410 00For
Vanguard846,2120 00For
Brown Advisory Funds508,7290 00For
Fidelity354,9890 00For
WASATCH FUNDS TRUST351,2260 00For
Dimensional331,3060 00For
BlackRock298,2750 00For
Jackson National201,7340 00For
Principal188,8260 00For
Charles Schwab124,4280 00For
PARADIGM FUNDS119,4000 00For
Goldman Sachs102,7720 00For
State Street92,865298 00For
Victory Capital76,6770 00For
Nationwide64,9520 00For
Royce55,6230 00For
New York Life52,4930 00For
Equitable41,1650 00For
MoA Funds Corp38,0390 00For
TIAA37,0460 00For
QUANTITATIVE MASTER SERIES LLC29,6090 00For
BUFFALO FUNDS28,4900 00For
CLEARWATER INVESTMENT TRUST28,0870 00For
PACE SELECT ADVISORS TRUST22,4780 00For
Harbor Funds II18,7750 00For

Fund voting reports, all 59 managers: 5,377,907 for, 17,351 against. Showing the 25 largest; see all in the interactive database.

Institutional-manager reports: 135 asset managers voting on “To approve, on an advisory basis, the compensation of our named executive officers.” at ORTHOPEDIATRICS CORP., 2023-2024
Asset managerForAgainst AbstainWithheldVote
BROWN CAPITAL MANAGEMENT LLC1,673,4890 00For
BROWN ADVISORY INC1,411,1175,802 00For
BRAIDWELL LP1,019,4900 00For
Wellington656,4000 00For
Granahan Investment Management, LLC572,6840 00For
NEW YORK STATE COMMON RETIREMENT FUND561,8960 00For
BlackRock491,1974,608 00For
WASATCH ADVISORS LP452,1360 00For
State Street395,558298 00For
GEODE CAPITAL MANAGEMENT, LLC367,8180 00For
RIVERBRIDGE PARTNERS LLC363,9530 00For
Prosight Management, LP167,5830 00For
Charles Schwab148,1500 00For
Northern Trust143,43512 00For
NEXT CENTURY GROWTH INVESTORS LLC108,4860 00For
FORMULA GROWTH LTD92,5240 00For
KENNEDY CAPITAL MANAGEMENT LLC75,00114,610 00Mixed
UBS66,09713,276 00Mixed
PARAMETRIC PORTFOLIO ASSOCIATES LLC73,7000 00For
MELLON INVESTMENTS Corp065,710 00Against
Dimensional54,8600 00For
Conestoga Capital Advisors, LLC48,6790 00For
NEW YORK STATE TEACHERS RETIREMENT SYSTEM45,4470 00For
Triodos Investment Management BV41,0000 00For
Vanguard39,1910 00For

Institutional-manager reports, all 135 managers: 9,443,068 for, 163,029 against, 34 not voted. Showing the 25 largest; see all in the interactive database.

6. Approval, on an advisory basis, of the appointment of Deloitte & Touche LLP as the Company's Independent Registered…

Official resultAUDIT-RELATEDReported outcome: Approved

Combines 3 wordings of this item as funds reported it.

99.2% Approved · of votes cast

FOR 99.2%
FOR: 20,565,406AGAINST: 150,366
Details: description as filed, official tally, votes by 59 asset managers

Description as filed by funds: To approve, on an advisory basis, the appointment of Deloitte & Touche LLP as our independent registered public accounting firm for our fiscal year ending December 31, 2024.

ORTHOPEDIATRICS CORP.’s own tally for this item (“Approval, on an advisory basis, of the appointment of Deloitte & Touche LLP as the Company's Independent Registered Public Accounting Firm for our Fiscal Year Ending December 31, 2024 The Company's stockholders approved ”): 20,565,406 for, 150,366 against — passed, per its Form 8-K filed May 28, 2024 (Item 5.07).

Reported outcome: Approved, in the filing’s own words: “Approval, on an advisory basis, of the appointment of Deloitte & Touche LLP as the Company's Independent Registered Public Accounting Firm for our Fiscal Year Ending December 31, 2024 The Company's stockholders approved the appointment by the Audit Committee of the Company's Board of Directors of D…”
Support: 99.2% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 59 asset managers below reported 5,394,767 for, 491 against.

FOR
FOR: 5,394,767AGAINST: 491
Largest asset managers voting on “To approve, on an advisory basis, the appointment of Deloitte & Touche LLP as our independent registered publi” at ORTHOPEDIATRICS CORP., 2023-2024
Asset managerForAgainst AbstainWithheldVote
Brown Capital Management Mutual Funds1,220,1410 00For
Vanguard846,2120 00For
Brown Advisory Funds508,7290 00For
Fidelity354,9890 00For
WASATCH FUNDS TRUST351,2260 00For
Dimensional331,3060 00For
BlackRock298,2750 00For
Jackson National201,7340 00For
Principal188,8260 00For
Charles Schwab124,4280 00For
PARADIGM FUNDS119,4000 00For
Goldman Sachs102,7720 00For
State Street92,672491 00For
Victory Capital76,6770 00For
Nationwide64,9520 00For
Royce55,6230 00For
New York Life52,4930 00For
Equitable41,1650 00For
MoA Funds Corp38,0390 00For
TIAA37,0460 00For
QUANTITATIVE MASTER SERIES LLC29,6090 00For
BUFFALO FUNDS28,4900 00For
CLEARWATER INVESTMENT TRUST28,0870 00For
PACE SELECT ADVISORS TRUST22,4780 00For
Harbor Funds II18,7750 00For

Showing the 25 largest of 59 asset managers. See all 59 in the interactive database.

Largest ORTHOPEDIATRICS CORP. shareholders voting in 2023-2024

Ranked separately for each type of Form N-PX report. An institutional manager can report shares that a fund it advises also reports, so the two tables can list the same shares and are never added together. Each is ranked by the shares voted on the item that the most managers of that type reported, shown as a share of the 23,828,882 shares outstanding at the time of that meeting.

Fund voting reports: top ORTHOPEDIATRICS CORP. shareholders by shares voted on “To approve, on an advisory basis, the compensation of our named executive officers.”, 2023-2024
#Asset manager % of shares outstanding
1Brown Capital Management Mutual Funds 5.12%
2Vanguard 3.55%
3Brown Advisory Funds 2.13%
4Fidelity 1.49%
5WASATCH FUNDS TRUST 1.47%
6Dimensional 1.39%
7BlackRock 1.25%
8Jackson National 0.85%
9Principal 0.79%
10Charles Schwab 0.52%
Institutional-manager reports: top ORTHOPEDIATRICS CORP. shareholders by shares voted on “To approve, on an advisory basis, the compensation of our named executive officers.”, 2023-2024
#Asset manager % of shares outstanding
1BROWN CAPITAL MANAGEMENT LLC 7.02%
2BROWN ADVISORY INC 5.95%
3BRAIDWELL LP 4.28%
4Wellington 2.75%
5Granahan Investment Management, LLC 2.40%
6NEW YORK STATE COMMON RETIREMENT FUND 2.36%
7BlackRock 2.08%
8WASATCH ADVISORS LP 1.90%
9State Street 1.66%
10GEODE CAPITAL MANAGEMENT, LLC 1.54%

Reported ORTHOPEDIATRICS CORP. holdings and ownership

As disclosed to the SEC in Form 13F (quarter-end holdings of 30 large managers), Schedules 13D and 13G (beneficial ownership above 5%) and the company’s own proxy statement (DEF 14A). Each row names its form.

ORTHOPEDIATRICS CORP. holdings and ownership disclosed for the 2023-2024 proxy season
Holder % outstanding Disclosure
David R. Pelizzon 29.06% DEF14A
Squadron Capital LLC 28.96% DEF14A
Brown Capital Management, LLC 13.93% DEF14A
Brown Advisory Incorporated 6.80% DEF14A
BlackRock 5.11% 13F
Morgan Stanley 4.66% 13F
Vanguard Group 4.03% 13F
Dimensional Fund Advisors 2.13% 13F
State Street 1.82% 13F
Geode Capital 1.54% 13F

Percentages above are of 23,828,882 shares outstanding, as reported by ORTHOPEDIATRICS CORP. on its Form 10-Q dated May 3, 2024 (see the filing on EDGAR). This is the count contemporaneous with the 2023-2024 meeting, not today’s. Each holding is as of its own filing, which may be dated before or after the meeting.

About this page

Every figure above is derived from filings made with the US Securities and Exchange Commission: Form N-PX, in which registered funds disclose how they voted every proxy and institutional managers disclose their votes on executive pay (say-on-pay, say-on-frequency and golden parachutes), and Form 8-K Item 5.07, in which the company reports its own meeting results. Shares outstanding are taken from ORTHOPEDIATRICS CORP.’s 10-Q dated May 3, 2024. This page is a static snapshot rebuilt weekly on October 14, 2026; a live search always shows the current data.

At ORTHOPEDIATRICS CORP.'s shareholder meeting held May 24, 2024, in the 2023-2024 proxy season, 177 asset managers reported how they voted on 6 ballot items in their SEC Form N-PX filings, covering 1,142 separate fund positions. On the most widely held item on that ballot — To approve, on an advisory basis, the compensation of our named executive officers. — ORTHOPEDIATRICS CORP.'s filing reports the proposal as approved, with 99% support of the votes cast (FOR divided by FOR plus AGAINST, the conventional basis for proxy support; abstentions, broker non-votes and unvoted shares are excluded because none of them took a side). Source: ORTHOPEDIATRICS CORP.'s Form 8-K, Item 5.07, filed with the U.S. Securities and Exchange Commission on May 28, 2024.

ORTHOPEDIATRICS CORP. proxy season coverage: 2023-2024 (this page) · 2024-2025 · 2025-2026.

Download data (CSV): ballot items · votes by manager · column guide.